Next Article in Journal
How to Improve SBRT Outcomes in NSCLC: From Pre-Clinical Modeling to Successful Clinical Translation
Next Article in Special Issue
RBM24 in the Post-Transcriptional Regulation of Cancer Progression: Anti-Tumor or Pro-Tumor Activity?
Previous Article in Journal
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
Previous Article in Special Issue
RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(7), 1704; https://doi.org/10.3390/cancers14071704
Action Date Notes Link
article xml file uploaded 27 March 2022 12:50 CEST Original file -
article xml uploaded. 27 March 2022 12:50 CEST Update -
article pdf uploaded. 27 March 2022 12:50 CEST Version of Record https://www.mdpi.com/2072-6694/14/7/1704/pdf-vor
article supplementary file uploaded. 27 March 2022 12:50 CEST - https://www.mdpi.com/2072-6694/14/7/1704#supplementary
article html file updated 27 March 2022 12:51 CEST Original file -
article xml file uploaded 6 April 2022 09:30 CEST Update -
article xml uploaded. 6 April 2022 09:30 CEST Update -
article html file updated 6 April 2022 09:32 CEST Update -
article xml file uploaded 6 April 2022 11:58 CEST Update -
article xml uploaded. 6 April 2022 11:58 CEST Update https://www.mdpi.com/2072-6694/14/7/1704/xml
article pdf uploaded. 6 April 2022 11:58 CEST Updated version of record https://www.mdpi.com/2072-6694/14/7/1704/pdf
article html file updated 6 April 2022 11:59 CEST Update -
article html file updated 2 August 2022 15:55 CEST Update https://www.mdpi.com/2072-6694/14/7/1704/html
Back to TopTop